.Welcome to this week's Chutes & Ladders, our summary of significant leadership hirings, shooting...
.Celebrating his firm's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the opening a...
.AbbVie has gone back to the resource of its own antipsychotic powerhouse Vraylar looking for an add...
.GenSight Biologics is weeks out of losing loan. Again. The biotech simply possesses sufficient mone...
.Monopar Therapeutics is actually recovering a drug coming from the dump of AstraZeneca's uncommon i...
.With brand new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of professio...
.After developing a gene therapy relationship with Dyno Therapies in 2020, Roche is actually back fo...
.Lundbeck is actually slashing the book value of its $250 million Abide Therapies buyout in action t...
.The assimilation of real-world information (RWD) into protocol workability and internet site select...
.At this year's Ferocious Biotech Top in Boston, we overtook forerunners in the biotech field who ha...